Literature DB >> 3513708

Microcystic adnexal carcinoma. Immunohistologic observations suggesting dual (pilar and eccrine) differentiation.

B J Nickoloff, H E Fleischmann, J Carmel, C C Wood, R J Roth.   

Abstract

Microcystic adnexal carcinoma (MAC) is a locally aggressive neoplasm that has recently been recognized as a clinicopathologic entity. Its histologic appearance includes both pilar and eccrine differentiation. We initially treated two patients with MAC of the cheek and of the nasolabial fold, respectively; by microscopically controlled excision because of the contiguous growth of the tumors. Despite the benign histologic appearance, there was deep and extensive infiltration of the subcutaneous tissue. Both patients responded favorably to initial treatment with microscopically controlled excision. In addition, immunoperoxidase staining for carcinoembryonic antigen supported the dual differentiation of this unusual neoplasm. We speculate that previous radiotherapy may be an important predisposing factor in the pathogenesis of MAC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513708     DOI: 10.1001/archderm.122.3.290

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Unusual presentation of primary orbital microcystic adnexal carcinoma.

Authors:  Wen Ying Wu-Chen; Christina Y Weng; K D A Rajan; Charles Eberhart; Neil R Miller
Journal:  J Neuroophthalmol       Date:  2011-06       Impact factor: 3.042

2.  Microcystic adnexal carcinoma in a non-Caucasian patient: A case report and review of the literature.

Authors:  Jingxin Chen; Shiping Yang; Jimin Chen; Tianan Liao; Wei Deng; Weizhong Li
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

3.  Microcystic adnexal carcinoma of the glabella in a liver transplant recipient.

Authors:  Christopher R Stamey; Oscar R Colegio; Samuel E Book
Journal:  JAAD Case Rep       Date:  2020-05-04

4.  Four calcium signaling pathway-related genes were upregulated in microcystic adnexal carcinoma: transcriptome analysis and immunohistochemical validation.

Authors:  Shuaixia Yu; Yang Wang; Baijie Tang; Xiang Liu; Linhong Song; Gang Xu; Hong Zhu; Huajun Sun
Journal:  World J Surg Oncol       Date:  2022-05-04       Impact factor: 3.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.